Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research
mehr
Storys zum Thema Gesundheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich
Aachen, Germany (ots) - Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic ...
mehrGrünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy
Aachen (ots) - Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat, a non-steroidal Selective Glucocorticoid ...
mehrGrünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist
Aachen (ots) - - The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. - In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. - A Phase II trial will commence later this year. Grünenthal announced today that the ...
mehrThe Virchow Prize 2026 Awarded for Pioneering Work on Ebola, Advancing Global Epidemic Preparedness and Fostering Global Solidarity
mehrLTS Lohmann Therapie-Systeme AG
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS’ Lakewood, New Jersey facility. The new offering focuses initially on product ...
mehr
VITUS Privatklinik Prof. Dr. Stehling GmbH
First Clinical Analysis of Electrochemotherapy in Prostate Cancer Shows 93% Response
OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 patients treated between 2017 and 2024. The report is the largest dataset to date on this treatment. Radical prostatectomy ...
mehrFIBO 2026: AI Drives the Longevity & Health Boom
Cologne (ots) - FIBO 2026, the world’s leading trade show for fitness, wellness, and health, marks a strategic shift in the industry toward data-driven health and longevity models. Where traditional strength training once dominated, digital applications, connected systems, and AI-powered analytics are now shaping market development. FIBO is positioning itself as an international platform and catalyst for a new ...
mehrServier delivers solid performance in 2024/25 and confirms its forecasts for 2030
Suresnes, France (ots/PRNewswire) - - Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. - Growth over the financial year was driven by increased sales in oncology, particularly in the United States. - Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. - Achieving 2025 ...
mehrSharjah Government Media Bureau
Sharjah Achieves Historic WHO Age-Friendly Status
SHARJAH, UAE (ots) - The Emirate of Sharjah, UAE, has reached a new global milestone by obtaining "Advanced Affiliate" membership in the World Health Organization’s (WHO) Global Network for Age-Friendly Cities and Communities. This makes Sharjah the first Arab city to achieve this prestigious status. This achievement underscores the emirate's deep commitment to enhancing the well-being of its senior residents and ...
mehr30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength
mehrHealth is a Political Choice: Global Leaders Call for Shared Responsibility at the World Health Summit, Gallup and GPMB Release Landmark Reports on Emotional Wellbeing and Pandemic Preparedness
mehr
Germans would value more trustworthy online health information
Gütersloh (ots) - Most people these days look online for answers to questions on health. However, many have doubts on the integrity and quality of the information provided by social media platforms and AI chatbots. The Bertelsmann Stiftung would like to contribute to promoting reliable sources and increasing confidence in digital information on health by means of its ...
mehrIEVA (Independent European Vape Alliance)
WHO must embrace harm reduction at COP11 to truly drive down global smoking rates
Brussels (ots) - As the 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) approaches (17–22 November 2025, Geneva), the Independent European Vape Alliance (IEVA) calls on the World Health Organization (WHO) and its member states to finally place harm reduction at the centre of the global tobacco control debate. IEVA ...
mehrFAMAR Group: Dr. Riku Rautsola Appointed New CEO
Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...
mehrServier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
mehrHealth in the fast lane: How modern car seats protect our backs
Bremervörde (Germany) (ots) - From autonomous driving to advanced safety technologies – the innovations presented at the IAA Mobility captivate car enthusiasts. However, one key comfort factor is often overlooked: the car seat. To meet the demand for ergonomic design, the production has become increasinglycomplex – up to 12 percent of a car’s development costs are attributable to the seat. “But not every seat ...
mehrCroma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...
mehr
ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.
Germany’s pharmacies under pressure: Statistical Yearbook 2025 now available
Berlin (ots) - ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the ...
mehrAxolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis
mehrHagleitner Hygiene International GmbH
Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year
mehrIEVA (Independent European Vape Alliance)
Majority of European Vapers Are Former Smokers: E-Cigarettes Offer Significant Harm Reduction Potential
Brussels (ots) - In the lead-up to World No Tobacco Day 2025 on 31 May, the Independent European Vape Alliance (IEVA) highlights compelling evidence that the majority of e-cigarette users in Europe are former smokers. This underscores the important role that vaping can play in tobacco harm reduction and as a tool to ...
mehrBundesinnung der Hörakustiker KdöR
Lübeck experts attend Arab Hearing Health Conference 2025 in Jordan / Campus Hearing Acoustics promotes international exchange of hearing health expertise
mehrCentor Launches Smart Pill Organizer to Support Medication Adherence
mehr
Data4Life releases Data2Evidence as open source: a new chapter for global health research
mehrDYMO® Partners with ELLKAY to Elevate the Healthcare Community with New Lab Enterprise Platform LKOrbit / The innovative cloud-based connectivity platform will expand outreach, streamline operations and increase revenue.
mehrX4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.
London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...
mehrBosch Healthcare Solutions GmbH
Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies
mehrNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
mehrGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
mehr
12345678Nächste